The Exosomes market is estimated to grow at a CAGR of 28.10% over the forecast period, from USD 1.90 billion in 2021 to USD 3.50 billion in 2027. (2022 - 2027).
Exosome-related techniques have improved rapidly in recent years, and the exosome market is expected to grow significantly as they are integrated into domains such as liquid biopsy, targeted therapy, and gene therapy. Cancer-derived exosomes, in particular, influence cell invasiveness by regulating angiogenesis, metastasis, and immune response, making them a highly significant source of biological indicators for cancer diagnosis, prognosis, and treatment classification.
With the rising prevalence of cancer, technological breakthroughs in exosome isolation and analytical procedures, an increasing number of scientific papers published on exosomes and their applications, a growing number of clinical trials being conducted to investigate exosome treatments and prognostics, and exosomes' increasingly enhanced innovative capabilities, the global exosomes market is expected to grow.
The report aspects discussed the profile of the top manufacturers of the global Exosomes market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Exosomes Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
02 November 2021 – Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strategic Collaboration--
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, announced today the acquisition of an exosome manufacturing facility located in Lexington, Massachusetts (US) from Codiak BioSciences, a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics.
The increased prevalence of diabetes around the world is expected to drive market expansion. Antimicrobial resistance, the adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are all key contributors to the growth in diabetes prevalence. Chronic diseases, such as respiratory disorders, diabetes, cancer, and cardiovascular diseases, currently account for almost 60.00 percent of all deaths and 43.00 percent of the global burden of disease, according to the WHO. By 2021, these percentages are expected to rise to around 73.00% and 60.00%, respectively. As the prevalence of chronic diseases rises, so will the demand for appropriate treatment alternatives.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America is expected to have the biggest market revenue due to substantial financing in the United States. The North American region retains one of the greatest shares of the market due to enhanced healthcare facilities, effective government initiatives, a significant foundation of multinational firms, and greater public awareness regarding diagnostics and Medicare.
Many government-funded scientific studies have been conducted on the efficacy of medications containing exosomes in numerous types of cancers, including melanoma, breast cancer, lung cancer, and pancreatic cancer, to name a few. Several academic institutions in the United States have endorsed and collaborated with corporations to conduct clinical trials. Aside from that, federal funding is heavily invested in these endeavours.
Asia Pacific is expected to emerge as the fastest-growing region due to the enormous capabilities revealed in developing nations such as China and India. Players' productive techniques for conducting research and development in this sector are a result of the government's continual backing, which is expected to bolster the Asia Pacific market's growth.
The Exosomes Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Exosomes Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 28.10% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | MBL International, Danaher Corporation (Beckman Coulter Inc.), Hologic Inc., Fujifilm Holdings Corporation, Lonza Group Ltd, JSR Corporation (MBL international), Miltenyi Biotec, Bio-Techne (Novus Biologicals), Qiagen, Thermo Fisher Scientific Inc., Illumina, Inc., Takara Bio Company, Malvern Instruments Ltd., Abcam PLC., Ampersand Capital Partner (New England Peptide, Inc.), Evox Therapeutics, Capricor Therapeutics Inc. |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 113 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Exosomes Market?
The Exosomes Market is growing at a CAGR of 28.10% over the next 5 years.
Who are the key players in Exosomes Market?
MBL International, Danaher Corporation (Beckman Coulter Inc.), Hologic Inc., Fujifilm Holdings Corporation, Lonza Group Ltd, JSR Corporation (MBL international), Miltenyi Biotec, Bio-Techne (Novus Biologicals), Qiagen, Thermo Fisher Scientific Inc., Illumina, Inc., Takara Bio Company, Malvern Instruments Ltd., Abcam PLC., Ampersand Capital Partner (New England Peptide, Inc.), Evox Therapeutics, Capricor Therapeutics Inc.
What are the significant types of Exosomes Market?
Non-coding RNAs, Lipids, mRNA, DNA fragments, Proteins /peptides
What are the major end-use applications of Exosomes Market?
Cancer, Infectious diseases, Neurodegenerative diseases, Cardiovascular diseases
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.